Call Us

ARTICLES

Arthrosamid®’s story started two decades ago. The brainchild of the team at Contura, the product had been in human use for various indications since 2000, and a favourable safety profile had already been established.

PATIENTS GAIN ACCESS TO INNOVATIVE NEW PROCEDURE FOR TREATING KNEE OSTEOARTHRITIS AS HCA UK PARTNERS WITH CONTURA ORTHOPAEDICS

London, September 2022; Contura Orthopaedics Ltd is pleased to announce that a major hospital group has signed up to Arthrosamid, allowing clinicians to offer this novel procedure to its patients in London and across the UK.

musculoskeletal disorders in addition to sporting injuries and complaints at its state-of-the-art facility located on Tottenham Court Road in Central London. The treatment will be rolled out across other facilities across the HCA Healthcare UK group in the coming months.

Arthrosamid is a polyacrylamide hydrogel first developed by Contura International Ltd. It is a long-lasting intra-articular injection approved in Europe for the treatment of knee OA. The treatment has the potential to change the present care pathway for managing OA, which affects approximately

Knee Injections for Osteoarthritis: Comparing Costs, Availability, and Patient Experiences in the UK

Explore the types, costs, and effectiveness of knee injections for osteoarthritis in the UK, including steroid, hyaluronic acid, hydrogel, and PRP therapies. Understand their availability on the NHS versus private care, typical patient experiences, side effects, and the latest research insights. Learn how these treatments differ from rheumatoid arthritis injections and what to expect during your knee injection journey to manage pain and improve mobility effectively.

Read More »

How Long Do Knee Gel Injections Last? A Patient-Centred Guide to Duration, Longevity Factors, and Repeat Treatment

Knee gel injections, primarily containing hyaluronic acid, are a common treatment for osteoarthritis pain, typically providing relief for about six months. The duration of effectiveness varies based on arthritis severity, age, body weight, activity level, and joint health. Newer options like polyacrylamide hydrogel (PAAG) show promise for longer relief, potentially lasting up to two years, especially in younger patients with milder arthritis. Repeat injections are safe and advisable when symptoms return, usually after six months. Consulting a healthcare professional ensures a tailored treatment plan for optimal pain management and improved mobility.

Read More »